| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2007 | US20070117761 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 05/24/2007 | US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration, |
| 05/24/2007 | US20070117750 Method for enhanced ocular drug penetration |
| 05/24/2007 | US20070117745 Cardio myopeptidin, the production and the use thereof |
| 05/24/2007 | US20070117744 nanoparticles comprising taxane and albumin, edetate, and sucrose; lyophilization; side effect reduction |
| 05/24/2007 | US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 05/24/2007 | US20070117138 Splice variant cannabinoid receptor (cb1b) |
| 05/24/2007 | US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116788 Method of enhancing motor function |
| 05/24/2007 | US20070116787 Cancer treatment |
| 05/24/2007 | US20070116786 A lipidic extract from lepidium meynii and its effect on the libido |
| 05/24/2007 | US20070116784 Imatinib combinations for head and neck cancers |
| 05/24/2007 | US20070116782 Use of rare earth compounds for the prevention of kidney stone disease |
| 05/24/2007 | US20070116780 Composition comprising sodium, potassium, calcium and magnesium |
| 05/24/2007 | US20070116778 Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases |
| 05/24/2007 | US20070116777 Ophthalmic preparation containing menthyl ester of indomethacin |
| 05/24/2007 | US20070116774 Methods and compositions for treating proliferative diseases |
| 05/24/2007 | US20070116771 Nanoparticles for protein drug delivery |
| 05/24/2007 | US20070116770 Tazobactam/piperacillin lyophilizate |
| 05/24/2007 | US20070116768 Sustained release preparations composed of biocompatible complex microparticles |
| 05/24/2007 | US20070116763 Sustained release oral preparations |
| 05/24/2007 | US20070116762 Compositions of stabilized ramipril in combination with another active agent |
| 05/24/2007 | US20070116761 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 05/24/2007 | US20070116760 Pharmaceutical compositions comprising meloxicam and methods of their preparation |
| 05/24/2007 | US20070116759 Pharmaceutical compositions of telmisartan |
| 05/24/2007 | US20070116758 Atorvastatin formulation |
| 05/24/2007 | US20070116757 Methylene Blue Derivatives |
| 05/24/2007 | US20070116756 Stable pharmaceutical compositions |
| 05/24/2007 | US20070116755 Dissolution of arterial cholesterol plaques by pharmacological preparation |
| 05/24/2007 | US20070116754 Dissolution of arterial cholesterol plaques by pharmacological preparation |
| 05/24/2007 | US20070116750 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 05/24/2007 | US20070116749 Method for treatment of cellulitis |
| 05/24/2007 | US20070116747 Disposable Plastic Glove with Antiseptic Coating |
| 05/24/2007 | US20070116746 Packaging items containing a human pheromone component |
| 05/24/2007 | US20070116743 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 05/24/2007 | US20070116742 Confectionary products containing a human pheromone component |
| 05/24/2007 | US20070116739 Resorbable thin membranes |
| 05/24/2007 | US20070116738 Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof |
| 05/24/2007 | US20070116731 Dermatological cream-gels containing avermectin compounds |
| 05/24/2007 | US20070116730 Pharmaceutical compositions |
| 05/24/2007 | US20070116727 Vaccines directed to cancer-associated carbohydrate antigens |
| 05/24/2007 | US20070116726 Immunisation against Chlamydia pneumoniae |
| 05/24/2007 | US20070116719 Vaccine delivery |
| 05/24/2007 | US20070116713 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| 05/24/2007 | US20070116705 NOVEL PDEs AND USES THEREOF |
| 05/24/2007 | US20070116698 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 05/24/2007 | US20070116696 Lotus and methyl donors |
| 05/24/2007 | US20070116695 Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116672 Treatment of rheumatic diseases |
| 05/24/2007 | US20070116670 providing a medicament for the therapy of YB-1 positive diseases, in particular of tumor diseases; expressing a gene or gene fragment in a tumor cell |
| 05/24/2007 | US20070116667 Colon cleansing compositions and methods |
| 05/24/2007 | US20070116666 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 05/24/2007 | US20070116665 Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses |
| 05/24/2007 | US20070116664 Methods and compositions for treating hair and skin afflictions |
| 05/24/2007 | US20070116657 Hair growth promotor composition |
| 05/24/2007 | US20070116654 Cosmetics |
| 05/24/2007 | US20070116649 Antibiotic formulations, unit doses, kits, and methods |
| 05/24/2007 | US20070116647 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 05/24/2007 | US20070114306 Microparticles, microparticle production method, and microparticle production apparatus |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | DE20321455U1 Stabilisiertes pharmazeutisches Erzeugnis, das einen amorphen Wirkstoff enthält A stabilized pharmaceutical product which contains an amorphous active ingredient |
| 05/24/2007 | DE102006053594A1 Verfahren zur Reinigung von Letrozol A process for purifying letrozole |
| 05/24/2007 | DE102006053593A1 Verfahren zur Herstellung von Letrozol Process for the preparation of letrozole |
| 05/24/2007 | DE102006006893B3 New aspoquinolone compounds useful in the preparation of anti-proliferative therapeutics |
| 05/24/2007 | DE102005056054B3 Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention von mindestens einer Atemwegserkrankung A pharmaceutical composition for the treatment and / or prevention of at least one respiratory disease |
| 05/24/2007 | DE102005055386A1 Non-aqueous fluid preparation for treating inflammatory diseases, comprises glucocorticoid esters of dexamethasone acetate or betamethasone valerate, and a sorbic acid, with the acid stabilising the ester preparation |
| 05/24/2007 | CA2636712A1 Pediculicide/ovicide composition |
| 05/24/2007 | CA2633636A1 Photoactivatable antimicrobial agents |
| 05/24/2007 | CA2632157A1 Process for metabolic control and high solute clearance and solutions for use therein |
| 05/24/2007 | CA2631166A1 Salts and mixture of -9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols, pharmaceutical compositions containing said agents and treatment methods |
| 05/24/2007 | CA2630952A1 Multitargeting interfering rnas having two active strands and methods for their design and use |
| 05/24/2007 | CA2630932A1 Multitargeting interfering rnas and methods of their use and design |
| 05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
| 05/24/2007 | CA2630441A1 Therapeutic uses of steroidal compounds |
| 05/24/2007 | CA2630368A1 Succinimide derivatives as ocular hypotensive agents |
| 05/24/2007 | CA2630360A1 Substituted bicyclic pyrimidone derivatives |
| 05/24/2007 | CA2630224A1 Organic compounds comprising a glycopyrrolium salt |
| 05/24/2007 | CA2630203A1 3,6-dihydro-2-oxo-6h-1,3,4-thiadiazine derivatives |
| 05/24/2007 | CA2630202A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h[1,3,4]-thiadiazines |
| 05/24/2007 | CA2630193A1 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 05/24/2007 | CA2630079A1 Pyrazolothiazole protein kinase modulators |
| 05/24/2007 | CA2629912A1 Novel process and formulations |
| 05/24/2007 | CA2629896A1 Isocystene derivatives for the treatment of pain |
| 05/24/2007 | CA2629863A1 Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors |
| 05/24/2007 | CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | CA2629815A1 Integrin-binding small molecules |
| 05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | CA2629785A1 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 05/24/2007 | CA2629781A1 Aminopyrimidines useful as kinase inhibitors |
| 05/24/2007 | CA2629714A1 Administration of an mtor inhibitor to treat patients with cancer |
| 05/24/2007 | CA2629683A1 Medicament for use in connection with cartilage impairment |
| 05/24/2007 | CA2629530A1 N-substituted indenoisoquinolines and syntheses thereof |
| 05/24/2007 | CA2629514A1 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 05/24/2007 | CA2629468A1 Pyrazolyl urea derivatives useful in the treatment of cancer |